You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches
Dermatology

Deeper Than the Surface:​ A Discussion on Atopic Dermatitis and Prurigo Nodularis in Clinical Practice

Curious about diagnostic considerations for atopic dermatitis and prurigo nodularis? Join experts Drs. Raj Chovatiya and Matt Zirwas at an educational symposium on diagnostic considerations for atopic dermatitis and prurigo nodularis and how clinical signs and itch in these diseases are impacted by type 2 inflammation.

Raj Chovatiya
Matthew Zirwas
MD, PhD, MSCI
Raj Chovatiya +1 more
Maui Derm_Events
Past event
21June2024
Location
The Broadmoor
1 Lake Avenue 80906 Colorado Springs USA

Learning objectives

  • Identify diagnostic considerations and challenges associated with atopic dermatitis and prurigo nodularis
  • Describe how clinical signs and itch in atopic dermatitis and prurigo nodularis are impacted by type 2 inflammation

Description

Join the ADVENT program at the Maui Derm 2024 conference in Colorado Springs for an engaging discussion on diagnostic considerations for atopic dermatitis and prurigo nodularis and how clinical signs and itch in these diseases are impacted by type 2 inflammation.

Don’t miss your opportunity to hear directly from Drs. Raj Chovatiya and Matt Zirwas as they share clinical pearls!

*This session does not offer CME credits
ls

Location

The Broadmoor
1 Lake Avenue 80906 Colorado Springs USA
Tags
symposiumtype 2 inflammation
MAT-US-2404437 v1.0 - P Exp Date: 05/16/2026

Speakers

Dermatology
MD, PhD, MSCI

Raj Chovatiya

Assistant Professor of Dermatology at the Northwestern University Feinberg School of Medicine in Chicago, US

Dermatology
MD

Matthew Zirwas

Matthew Zirwas, MD, is an American Board of Dermatology-certified physician. He is a nationally known expert who has been specializing in contact dermatitis, pruritus, atopic dermatitis, and seborrheic dermatitis for the last 20 years.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi | Regeneron Logo

© 2024 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v3.0-P Exp. Date: 11/24/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region